← The Wire
BSXNYSE
BOSTON SCIENTIFIC CORP
Surgical & Medical Instruments & Apparatus · DE · CIK 885725
Develops, manufactures, and markets medical devices for various healthcare markets
🔥 High media attention
$69.72B
Market cap
$43.48
Last close
-1.7%
1D
-1.9%
5D
21.9M
Volume
Price · last 39 sessions-23.5%
May 4L $43.48 · H $57.78Jun 29
149
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
11-K11-KJun 24, 20268-KCompany UpdateMay 18, 20268-KCompany UpdateMay 18, 20268-KBylaw Amendment · Shareholder VoteMay 5, 202610-Q10-QMay 1, 2026425425Apr 22, 20268-KResults of OperationsApr 22, 20268-KCompany UpdateMar 30, 2026DEFA14ADEFA14AMar 18, 2026DEF 14ADEF 14AMar 18, 2026425425Mar 3, 2026S-4S-4Feb 27, 20268-KMaterial Agreement · Agreement TerminatedFeb 26, 20268-KExecutive Change · Reg FD DisclosureFeb 23, 202610-K10-KFeb 17, 20268-KExecutive ChangeFeb 5, 2026425FORM 425Feb 4, 20268-KResults of OperationsFeb 4, 2026425FORM 425Jan 20, 2026425FORM 425Jan 20, 2026425FOR 425Jan 15, 2026425FORM 425Jan 15, 2026425CURRENT REPORTJan 15, 20268-KMaterial AgreementJan 15, 2026425CURRENT REPORTJan 15, 20268-KReg FD DisclosureJan 15, 20268-KExecutive ChangeNov 19, 202510-Q10-QNov 3, 20258-KExecutive ChangeOct 23, 20258-KResults of OperationsOct 22, 20258-KExecutive ChangeSep 4, 202510-Q10-QAug 1, 20258-KResults of OperationsJul 23, 202511-K11-KJun 18, 20258-KCompany UpdateMay 28, 20258-KShareholder VoteMay 6, 202510-Q10-QMay 1, 20258-KExecutive Change · Company UpdateApr 23, 20258-KResults of OperationsApr 23, 2025DEFA14ADEFA14AMar 19, 2025DEF 14ADEF 14AMar 19, 20258-KMaterial Agreement · New Debt / ObligationFeb 26, 2025424B5424B5Feb 21, 202510-K10-KFeb 18, 20258-KExecutive ChangeFeb 12, 20258-KResults of OperationsFeb 5, 20258-KCompany UpdateJan 16, 20258-KExecutive ChangeNov 22, 20248-KCompany UpdateNov 15, 20248-KReg FD DisclosureNov 7, 202410-Q10-QNov 1, 20248-KResults of OperationsOct 23, 202410-Q10-QAug 1, 20248-KExecutive Change · Reg FD DisclosureJul 30, 20248-KResults of OperationsJul 24, 202411-KFY 2023 11-KJun 13, 20248-KExecutive Change · Bylaw AmendmentMay 10, 20248-KBylaw Amendment · Shareholder VoteMay 6, 202410-Q10-QMay 1, 2024DEFA14ADEFA14AApr 29, 20248-KResults of OperationsApr 24, 20248-KCompany UpdateApr 4, 2024DEFA14ADEFA14AMar 20, 2024DEF 14ADEF 14AMar 20, 20248-KMaterial Agreement · New Debt / ObligationFeb 27, 2024424B5424B5Feb 22, 202410-K/A10-K/AFeb 21, 202410-K10-KFeb 20, 20248-KExecutive ChangeJan 31, 20248-KResults of OperationsJan 31, 20248-KMaterial AgreementJan 8, 20248-KReg FD DisclosureJan 8, 20248-KExecutive ChangeNov 22, 202310-Q10-QNov 1, 20238-KResults of OperationsOct 26, 202310-Q10-QAug 3, 20238-KResults of OperationsJul 27, 20238-KExecutive Change · Reg FD DisclosureJun 27, 202311-KFY 2022 11-KJun 15, 20238-KCompany UpdateJun 6, 2023
Insider Activity
In the 90 days to Feb 2, 2026: 3 sold $18.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 2, 2026 | Mahoney Michael FChairman, President & CEO | Sell | 159,701 | $93.49 | $14.9M |
| Feb 2, 2026 | Mahoney Michael FChairman, President & CEO | Sell | 1,200 | $94.06 | $113K |
| Dec 1, 2025 | Butcher Arthur CEVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $101.55 | $1.8M |
| Nov 6, 2025 | Zane Ellen MDirector | Sell | 12,891 | $98.28 | $1.3M |
| Nov 3, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 29,472 | $99.14 | $2.9M |
| Nov 3, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 16,928 | $99.76 | $1.7M |
| Nov 3, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 3,600 | $100.75 | $363K |
| Oct 28, 2025 | Zane Ellen MDirector | Sell | 2,901 | $102.24 | $297K |
| Oct 27, 2025 | Zane Ellen MDirector | Sell | 9,990 | $101.13 | $1.0M |
| Oct 1, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 41,755 | $98.38 | $4.1M |
| Oct 1, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 8,245 | $98.91 | $816K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 6 reputable articles · skews ▼ negative.
MarketWatchBoston Scientific Corp. stock underperforms Monday when compared to competitors12h agoMarketWatchBoston Scientific Corp. stock underperforms Wednesday when compared to competitors12d agoMarketWatchBoston Scientific Corp. stock underperforms Thursday when compared to competitors18d agoMarketWatchBoston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains25d agoFortuneBoston Scientific (BSX): Company Profile, Stock Price, News, Rankings27d agoBarron'sOur Boston Scientific Pick Has Suffered. We’re Pulling the Recommendation.1mo ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance